लोड हो रहा है...

EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis

EZH2 is a Polycomb group protein that exerts oncogenic functions in breast cancer, where its overexpression is associated with metastatic disease. While it reportedly acts a transcriptional repressor through trimethylation of histone H3 at lysine 27, EZH2 may exhibit context-dependent activating fun...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Moore, Heather M., Gonzalez, Maria E., Toy, Kathy A., Cimino-Mathews, Ashley, Argani, Pedram, Kleer, Celina G.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2013
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3690767/
https://ncbi.nlm.nih.gov/pubmed/23539298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2498-x
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!